Is ED a Warning Sign of Heart Disease? Alberta Guide

The Vascular Connection: ED as a Cardiovascular Sentinel

The relationship between erectile dysfunction and cardiovascular disease is one of the most clinically significant discoveries in men's health over the past two decades. What was once dismissed as a "bedroom problem" is now recognized by cardiologists and urologists alike as a potential early warning sign of systemic vascular disease — often appearing 2 to 5 years before a cardiac event.

Understanding this connection is not academic. For men in Edmonton and Calgary, it could be the difference between proactive health management and a preventable cardiovascular emergency.

> "When a man presents with new-onset erectile dysfunction and no obvious psychological cause, I think cardiovascular risk first. The penile artery is the canary in the coal mine of vascular health. Ignoring ED isn't just a sexual health decision — it's a cardiovascular health decision." > — Dr. Lloyd Tapper, PhD, NP — Founder, ReGenesis

The Artery Size Hypothesis

The physiological basis for the ED–cardiovascular disease connection is elegantly simple. It comes down to artery diameter:

• Penile arteries: 1–2mm in diameter
• Coronary arteries (heart): 3–4mm in diameter
• Carotid arteries (brain): 5–7mm in diameter

When atherosclerosis — the progressive buildup of plaque within arterial walls — begins, it affects all arteries simultaneously. However, the clinical symptoms appear first in the smallest vessels, because a smaller absolute reduction in lumen diameter produces a proportionally greater reduction in blood flow.

This means that the same disease process that will eventually cause a heart attack or stroke manifests first as erectile dysfunction — typically 2–5 years before cardiac symptoms emerge.

This concept, termed the "artery size hypothesis," was formalized by Montorsi et al. (2003, European Urology) and has since been validated in numerous large-scale studies.

The Evidence: What the Research Shows

The body of evidence linking ED to cardiovascular disease is extensive and compelling:

The Thompson Study (JAMA, 2005) The Prostate Cancer Prevention Trial followed 9,457 men over seven years. Men with ED at baseline had a **45% increased risk** of cardiovascular events (heart attack, stroke, angina) compared to men without ED — even after adjusting for traditional risk factors.

The Inman Study (Mayo Clinic, 2009) A 10-year prospective cohort study of 1,402 men found that ED was associated with an **80% higher risk** of coronary artery disease. For men under 50 with ED, the cardiovascular risk was particularly elevated — suggesting that younger men with ED warrant especially careful cardiovascular screening.

The Vlachopoulos Meta-Analysis (2013) A comprehensive meta-analysis of 36,744 men published in the *European Heart Journal* found that ED was associated with: - **44% increased risk** of cardiovascular events - **62% increased risk** of myocardial infarction (heart attack) - **39% increased risk** of cerebrovascular events (stroke) - **25% increased risk** of all-cause mortality

The Princeton III Consensus (2012) Following the accumulated evidence, the Third Princeton Consensus Conference — a joint statement from cardiologists and sexual medicine specialists — formally recommended that **all men presenting with ED should undergo cardiovascular risk assessment**.

> "The Princeton Consensus changed the clinical landscape. ED is no longer just a quality-of-life concern — it's a cardiovascular risk marker that demands evaluation. That's exactly how we approach it at ReGenesis." > — Dr. Lloyd Tapper, PhD, NP

Shared Pathophysiology: Endothelial Dysfunction

The common denominator linking ED and cardiovascular disease is endothelial dysfunction — damage to the endothelium, the single-cell-thick inner lining of all blood vessels.

Healthy endothelial cells produce nitric oxide (NO), a vasodilator that relaxes smooth muscle in blood vessel walls, allowing increased blood flow. Nitric oxide is essential for erection — it triggers the cascade that relaxes the corpus cavernosum and allows penile engorgement.

When the endothelium is damaged — by hypertension, diabetes, smoking, high cholesterol, inflammation, or oxidative stress — nitric oxide production declines. Blood vessels lose their ability to dilate on demand. The result:

• In the penis: erectile dysfunction
• In the heart: angina, myocardial infarction
• In the brain: transient ischemic attack, stroke
• In the legs: peripheral arterial disease

Shared Risk Factors

ED and cardiovascular disease share virtually identical modifiable risk factors:

What This Means for Edmonton & Calgary Men

If you're experiencing erectile dysfunction — particularly if it's new onset, progressive, or associated with other vascular symptoms — it may be the most important early warning sign your body can give you.

The ReGenesis Cardiovascular-ED Assessment

At our Edmonton and Calgary clinics, every ED evaluation includes a comprehensive cardiovascular risk profile:

• Blood pressure: Screening for hypertension (a major ED and CVD driver)
• Lipid panel: Total cholesterol, LDL, HDL, triglycerides
• Fasting glucose and HbA1c: Diabetes and pre-diabetes screening
• High-sensitivity CRP: Systemic inflammation marker
• Homocysteine: Independent cardiovascular risk factor
• Testosterone panel: Total testosterone, free testosterone, SHBG
• Body composition: BMI, waist circumference, body fat percentage
• Complete medication review: Identifying drugs that may contribute to both ED and cardiovascular risk
• Family history assessment: Genetic cardiovascular risk factors

> "We don't just treat the erection — we evaluate the entire vascular system. Many of our patients have told us that their ReGenesis assessment was the most comprehensive cardiovascular evaluation they've ever received. That's how it should be." > — Dr. Lloyd Tapper, PhD, NP

Action Steps: What to Do If You're Experiencing ED

1. Don't ignore it: ED is a medical condition with potentially serious health implications
2. Get a comprehensive assessment: Not just a prescription — a full cardiovascular and hormonal evaluation
3. Address underlying risk factors: Lifestyle modifications benefit both your cardiovascular health and your erectile function
4. Follow up regularly: Ongoing monitoring ensures optimal treatment and early detection of cardiovascular changes
5. Communicate with your partner: ED affects relationships; open communication reduces anxiety and improves outcomes

The Bottom Line

Erectile dysfunction is not just about sexual performance. It is, in many cases, the earliest detectable marker of cardiovascular disease — appearing years before a heart attack or stroke. For men in Edmonton and Calgary, taking action on ED is an investment in longevity.

At ReGenesis, we treat both the symptom and the system. Your ED assessment is simultaneously a cardiovascular risk evaluation — because your vascular health doesn't compartmentalize, and neither should your healthcare.

References

1. Montorsi F, et al. Association between erectile dysfunction and coronary artery disease. *European Urology*. 2003;44(3):360-365.
2. Thompson IM, et al. Erectile dysfunction and subsequent cardiovascular disease. *JAMA*. 2005;294(23):2996-3002.
3. Inman BA, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. *Mayo Clinic Proceedings*. 2009;84(2):108-113.
4. Vlachopoulos CV, et al. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis. *European Heart Journal*. 2013;34(31):2034-2046.
5. Nehra A, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. *Mayo Clinic Proceedings*. 2012;87(8):766-778.
6. Gandaglia G, et al. A systematic review of the association between erectile dysfunction and cardiovascular disease. *European Urology*. 2014;65(5):968-978.

Schedule Your Assessment

Confidential assessments available. Same-week appointments for new patients.

Ready to Take the Next Step?

Book a confidential assessment with a ReGenesis clinician.

Call 587.635.3414